Health TrialsbyHealthPanel

Comparative Analysis of the Impact of Transversus Abdominis Plane Block on Post-Cesarean Pain Management Using Low Concentration Ropivacaine 0,2%

ConditionsPostoperative PainPostoperative Acute Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMatild Keresztes

About this trial

The goal of this clinical trial is to evaluate whether the addition of a Transversus Abdominis Plane (TAP) block improves postoperative outcomes in women undergoing cesarean section.

The main questions it aims to answer are:

Does the TAP block reduce postoperative pain scores compared with the traditional analgesic regimen used in our hospital? Does the TAP block decrease opioid consumption within the first 24 hours? Does the TAP block improve the 24-hour quality of recovery? Researchers will compare patients receiving the traditional analgesic regimen with patients who receive the TAP block in addition to standard care to determine differences in pain management, opioid requirements, and recovery quality.

Participants will:

Receive standard anesthetic and perioperative care for cesarean delivery. Be randomized to either the TAP block group or the traditional analgesic regimen group.

Have postoperative pain scores assessed at predefined intervals. Have opioid consumption recorded within the first 24 hours. Complete a quality-of-recovery assessment at 24 hours postoperatively.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Postoperative analgesia using TAP block, Ropivacaine 0,2%, volume: 0,4 ml/kg per side

    Drug

    Postoperative (post cesarean section) TAP block using low concentration Ropivacaine ( 0,2%), volume dose weight calculated: 0,4 ml/kg per side. Total ropivacaine dose 1,6 mg/kg.

  • Postoperative pain management using "traditional" analgesia iv regime

    Drug

    "Traditional" analgesia refers to our analgesia technique used in our hospital. Regular Tramadol, Metamizol, +/- Ibuprofen/Dexketorpofen/Parecoxib

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Postoperative (c-section) TAP blockActive comparator 1 intervention
Group B: "Traditional" analgesia regimen after c-sectionOther 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative opioid consumption

Time frame
24 hours

Secondary outcomes

1

Recovery after cesarean section using the ObsQoR-11

The ObsQoR-11 is an 11-item, self-report questionnaire used to assess recovery after childbirth, particularly caesarean delivery after 24 hours. It measures four key aspects of recovery: physical comfort, emotional state, physical independence, and the ability to care for the newborn. A higher ObsQoR-11 score indicates better recovery

Time frame
24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Matild Keresztes

Lead sponsor

Tîrgu Mureș Emergency Clinical County Hospital, Romania

Sponsor institution

Tîrgu Mureș Emergency Clinical County Hospital, Romania

Collaborator

Source ClinicalTrials.gov
Apply now